<?xml version="1.0" encoding="UTF-8"?><mods xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" ID="id-95-18325">
    <name type="corporate">
        <namePart>United States Government Publishing Office</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">publisher</roleTerm>
            <roleTerm authority="marcrelator" type="code">pbl</roleTerm>
        </role>
        <role>
            <roleTerm authority="marcrelator" type="text">distributor</roleTerm>
            <roleTerm authority="marcrelator" type="code">dst</roleTerm>
        </role>
    </name>
    <name type="corporate">
        <namePart>United States</namePart>
        <namePart>National Archives and Records Administration</namePart>
        <namePart>Office of the Federal Register</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">author</roleTerm>
            <roleTerm authority="marcrelator" type="code">aut</roleTerm>
        </role>
        <description>Government Organization</description>
    </name>
    <typeOfResource>text</typeOfResource>
    <genre authority="marcgt">government publication</genre>
    <language>
        <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
    </language>
    <extension>
        <collectionCode>FR</collectionCode>
        <category>Regulatory Information</category>
        <waisDatabaseName>1995_register</waisDatabaseName>
        <branch>executive</branch>
        <dateIngested>2010-09-25</dateIngested>
    </extension>
    <genre authority="marcgt">article</genre>
    <titleInfo>
        <title>Civil Money Penalties: Biologics, Drugs, and Medical Devices</title>
        <partNumber>Part III</partNumber>
        <partName>Rules and Regulations</partName>
    </titleInfo>
    <relatedItem type="otherFormat" xlink:href="https://www.govinfo.gov/content/pkg/FR-1995-07-27/html/95-18325.htm">
        <identifier type="FDsys Unique ID">D09002ee1be05bf7f</identifier>
    </relatedItem>
    <relatedItem type="otherFormat" xlink:href="https://www.govinfo.gov/content/pkg/FR-1995-07-27/pdf/95-18325.pdf">
        <identifier type="FDsys Unique ID">D09002ee1be05c029</identifier>
    </relatedItem>
    <name type="corporate">
        <namePart>United States</namePart>
        <namePart>Notice</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">originator</roleTerm>
            <roleTerm authority="marcrelator" type="code">org</roleTerm>
        </role>
        <description>United States Government Agency or Subagency</description>
    </name>
    <name type="corporate">
        <namePart>United States</namePart>
        <namePart>Department of Health and Human Services</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">originator</roleTerm>
            <roleTerm authority="marcrelator" type="code">org</roleTerm>
        </role>
        <description>United States Government Agency or Subagency</description>
    </name>
    <name type="corporate">
        <namePart>United States</namePart>
        <namePart>Food and Drug Administration</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">originator</roleTerm>
            <roleTerm authority="marcrelator" type="code">org</roleTerm>
        </role>
        <description>United States Government Agency or Subagency</description>
    </name>
    <abstract>The Food and Drug Administration (FDA) is issuing final regulations to establish hearing procedures for use when FDA proposes the imposition of administrative civil money penalties. This rule implements the civil money penalty provisions of several statutes: the National Childhood Vaccine Injury Act of 1986 (NCVIA), the Prescription Drug Marketing Act of 1988 (PDMA), the Safe Medical Devices Act of 1990 (SMDA), the Generic Drug Enforcement Act of 1992 (GDEA), and the Mammography Quality Standards Act of 1992 (MQSA).</abstract>
    <identifier type="FR citation">60 FR 38612</identifier>
    <identifier type="uri">https://www.govinfo.gov/app/details/FR-1995-07-27/95-18325</identifier>
    <identifier type="FR Doc No.">95-18325</identifier>
    <identifier type="former granule identifier">fr27jy95-17</identifier>
    <identifier type="Regulation ID Number">RIN 0905-AD59</identifier>
    <identifier type="billing code">4160-01-P</identifier>
    <identifier type="department code">Docket No. 91N-0447</identifier>
    <location>
        <url displayLabel="Content Detail" access="object in context">https://www.govinfo.gov/app/details/FR-1995-07-27/95-18325</url>
        <url access="raw object" displayLabel="HTML rendition">https://www.govinfo.gov/content/pkg/FR-1995-07-27/html/95-18325.htm</url>
        <url access="raw object" displayLabel="PDF rendition">https://www.govinfo.gov/content/pkg/FR-1995-07-27/pdf/95-18325.pdf</url>
    </location>
    <physicalDescription>
        <extent>22 p.</extent>
    </physicalDescription>
    <part type="Part III">
        <extent unit="pages">
            <start>38612</start>
            <end>38633</end>
        </extent>
    </part>
    <identifier type="preferred citation">60 FR 38612</identifier>
    <relatedItem type="isReferencedBy">
        <titleInfo>
            <title>Code of Federal Regulations</title>
            <partNumber>Title 21 Part 10</partNumber>
        </titleInfo>
        <identifier type="CFR citation">21 CFR Part  10</identifier>
    </relatedItem>
    <relatedItem type="isReferencedBy">
        <titleInfo>
            <title>Code of Federal Regulations</title>
            <partNumber>Title 21 Part 17</partNumber>
        </titleInfo>
        <identifier type="CFR citation">21 CFR Part  17</identifier>
    </relatedItem>
    <relatedItem type="isReferencedBy">
        <titleInfo>
            <title>Code of Federal Regulations</title>
            <partNumber>Title 21 Part 20</partNumber>
        </titleInfo>
        <identifier type="CFR citation">21 CFR Part  20</identifier>
    </relatedItem>
    <relatedItem type="isReferencedBy">
        <titleInfo>
            <title>Code of Federal Regulations</title>
            <partNumber>Title 21 Part 5</partNumber>
        </titleInfo>
        <identifier type="CFR citation">21 CFR Part  5</identifier>
    </relatedItem>
    <relatedItem type="isReferencedBy">
        <titleInfo>
            <title>Code of Federal Regulations</title>
            <partNumber>Title 21 Part 5et al.</partNumber>
        </titleInfo>
        <identifier type="CFR citation">21 CFR Part  5et al.</identifier>
    </relatedItem>
    <relatedItem type="isReferencedBy">
        <titleInfo>
            <title>Regulation Identification Number 0905-AD59</title>
        </titleInfo>
        <identifier type="regulation ID number">RIN 0905-AD59</identifier>
    </relatedItem>
    <extension>
        <searchTitle>Civil Money Penalties: Biologics, Drugs, and Medical Devices; Federal Register Vol. 60, Issue </searchTitle>
        <granuleClass>RULE</granuleClass>
        <accessId>95-18325</accessId>
        <partNumber>III</partNumber>
        <agency order="1">Notice</agency>
        <agency order="2">DEPARTMENT OF HEALTH AND HUMAN SERVICES</agency>
        <agency order="3">Food and Drug Administration</agency>
        <departmentDoc>Docket No. 91N-0447</departmentDoc>
        <rin number="0905-AD59"/>
        <billingCode>4160-01-P</billingCode>
        <frDocNumber>95-18325</frDocNumber>
        <action>Final rule.</action>
        <summary>The Food and Drug Administration (FDA) is issuing final regulations to establish hearing procedures for use when FDA proposes the imposition of administrative civil money penalties. This rule implements the civil money penalty provisions of several statutes: the National Childhood Vaccine Injury Act of 1986 (NCVIA), the Prescription Drug Marketing Act of 1988 (PDMA), the Safe Medical Devices Act of 1990 (SMDA), the Generic Drug Enforcement Act of 1992 (GDEA), and the Mammography Quality Standards Act of 1992 (MQSA).</summary>
        <dates>August 28, 1995.</dates>
        <contact>Joseph M. Sheehan, Center for Devices and Radiological Health (HFZ-84), Food and Drug Administration, 2098 Gaither Rd., Rockville MD 20850, 301-594-4765.</contact>
        <cfr title="21">
                                    
            <part number="10"/>
                                
        </cfr>
        <cfr title="21">
                                    
            <part number="17"/>
                                
        </cfr>
        <cfr title="21">
                                    
            <part number="20"/>
                                
        </cfr>
        <cfr title="21">
                                    
            <part number="5"/>
                                
        </cfr>
        <cfr title="21">
                                    
            <part detail="et al." number="5"/>
                                
        </cfr>
    </extension>
    <relatedItem type="host" ID="P0b002ee180a8e49c" xlink:href="https://www.govinfo.gov/metadata/pkg/FR-1995-07-27/mods.xml">
        <titleInfo>
            <title>Federal Register</title>
            <partNumber>Vol. 60, no. 144</partNumber>
        </titleInfo>
        <originInfo>
            <publisher>Office of the Federal Register, National Archives and Records Administration</publisher>
            <dateIssued encoding="w3cdtf">1995-07-27</dateIssued>
            <issuance>continuing</issuance>
            <frequency>daily</frequency>
        </originInfo>
        <physicalDescription>
            <note type="source content type">deposited</note>
            <digitalOrigin>born digital</digitalOrigin>
            <extent>198 p.</extent>
        </physicalDescription>
        <tableOfContents xlink:href="https://www.govinfo.gov/app/frtoc/1995-07-27">    
		  Table of Contents: 
		</tableOfContents>
        <classification authority="sudocs">AE 2.7:</classification>
        <classification authority="sudocs">GS 4.107:</classification>
        <classification authority="sudocs">AE 2.106:</classification>
        <classification authority="lcc">KF70.A2</classification>
        <identifier type="uri">https://www.govinfo.gov/app/details/FR-1995-07-27</identifier>
        <identifier type="local">P0b002ee180a8e49c</identifier>
        <identifier type="issn">0097-6326</identifier>
        <identifier type="issn">0042-1219</identifier>
        <identifier type="issn">0364-1406</identifier>
        <identifier type="stock number">769-004-00000-9</identifier>
        <identifier type="ILS system id">000582072</identifier>
        <identifier type="former identifier">f:fr27jy95</identifier>
        <location>
            <url displayLabel="Content Detail" access="object in context">https://www.govinfo.gov/app/details/FR-1995-07-27</url>
            <url displayLabel="PDF rendition" access="raw object">https://www.govinfo.gov/content/pkg/FR-1995-07-27/pdf/FR-1995-07-27.pdf</url>
        </location>
        <accessCondition type="GPO scope determination">fdlp</accessCondition>
        <part type="issue">
            <extent unit="pages">
                <start>38475</start>
                <end>38663</end>
            </extent>
        </part>
        <recordInfo>
            <recordContentSource authority="marcorg">DGPO</recordContentSource>
            <recordCreationDate encoding="w3cdtf">2010-09-25</recordCreationDate>
            <recordChangeDate encoding="w3cdtf">2023-05-07</recordChangeDate>
            <recordIdentifier source="DGPO">FR-1995-07-27</recordIdentifier>
            <recordOrigin>machine generated</recordOrigin>
            <languageOfCataloging>
                <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
            </languageOfCataloging>
        </recordInfo>
        <extension>
            <docClass>FR</docClass>
            <accessId>FR-1995-07-27</accessId>
            <volume>60</volume>
            <issue>144</issue>
        </extension>
    </relatedItem>
</mods>
